Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Stroke Telemedicine for Arizona Rural Residents Trial (STARR)

This study has been completed.
Sponsor:
Collaborator:
Arizona Department of Health Services
Information provided by (Responsible Party):
Mayo Clinic
ClinicalTrials.gov Identifier:
NCT00829361
First received: January 26, 2009
Last updated: May 31, 2012
Last verified: May 2012
  Purpose

The STARR network registry consists of a 4 spoke 1 hub system. Which will consist of prospective collection, recording, and regular analysis of telestroke patient consultation and care data for the purpose of quality measure assessment and improvement and benchmarking against other national and international telestroke programs.


Condition Intervention
Stroke
Cerebral Infarction
Vascular Diseases
Brain Ischemia
Brain Infarction
Brain Diseases
Cerebrovascular Disorders
Other: Telemedicine

Study Type: Interventional
Study Design: Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Stroke Telemedicine for Arizona Rural Residents Trial

Resource links provided by NLM:


Further study details as provided by Mayo Clinic:

Primary Outcome Measures:
  • To assess the numbers of patients who receive thrombolytics and the time to treatment in patients evaluated by telemedicine [ Time Frame: 90 days ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • To assess the functional outcomes of acute stroke subjects by Barthel index and Modified Rankin Scale [ Time Frame: 90 days ] [ Designated as safety issue: No ]
  • To assess the rate of intracranial hemorrhage post thrombolysis [ Time Frame: 90 days ] [ Designated as safety issue: Yes ]

Enrollment: 447
Study Start Date: October 2008
Study Completion Date: January 2012
Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: Telemedicine
    Two way site independent audio/video telemedicine system with DICOM.
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients presenting to Rural Emergency Department within 12 hours of acute stroke symptom onset.
  • Written informed consent.

Exclusion Criteria:

  • Unlikely to complete study through 90-day follow-up.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00829361

Locations
United States, Arizona
Mayo Clinic Hospital
Phoenix, Arizona, United States, 85054
Sponsors and Collaborators
Mayo Clinic
Arizona Department of Health Services
Investigators
Principal Investigator: Bart M. Demerschalk, M.D. Mayo Clinic
Principal Investigator: Bentley J. Bobrow, M.D. Mayo Clinic
Study Director: Dwight D Channer, MS Mayo Clinic
  More Information

Additional Information:
No publications provided by Mayo Clinic

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Mayo Clinic
ClinicalTrials.gov Identifier: NCT00829361     History of Changes
Other Study ID Numbers: 08-005156
Study First Received: January 26, 2009
Last Updated: May 31, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Mayo Clinic:
Telemedicine
Acute stroke
Rural
thrombosis
consultation
Stroke
Cerebral Infarction
Vascular diseases
brain ischemia
brain infarction
brain diseases
cerebrovascular disorders

Additional relevant MeSH terms:
Brain Diseases
Brain Infarction
Brain Ischemia
Cerebral Infarction
Cerebrovascular Disorders
Infarction
Ischemia
Stroke
Vascular Diseases
Cardiovascular Diseases
Central Nervous System Diseases
Necrosis
Nervous System Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on November 20, 2014